课题基金 / 基金详情

BEHAVIORAL EFFECTS AND ABUSE OF DRUGS--ANTIHISTAMINES

BEHAVIORAL EFFECTS AND ABUSE OF DRUGS--ANTIHISTAMINES
行为影响和药物滥用——抗组胺药
批准号:
3208397
负责人:
JACK BERGMAN
金额:
$10.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-08-01 至 1987-07-31

项目摘要

项目成果

JACK BERGMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Histamine antagonists often have troublesome side effects in therapeutic application and may be used illicitly in combination with other drugs (e.g., "T's and Blues") by certain drug-dependent populations. Preliminary results from our laboratory indicate that selected histamine antagonists can have pronounced behavioral effects in monkeys and, like prototypical drugs of abuse, can maintain persistent drug-taking behavior. The objective of the proposed research is to identify pharmacological and environmental factors that determine how these drugs affect behavior. The actions of histamine H-1 and H-2 antagonists on scheduled-controlled behavior will be studied by determining their effects on suppressed and nonsuppressed responding under different environmental conditions, by comparing their effects with the effects of drugs from other pharmacological classes, and by comparing their effects when administered by central and peripheral routes. The reinforcing actions of histamine antagonists will be studied by determining their effects in initiating and maintaining self-administration behavior, by comparing their effects with the reinforcing effects of other drugs, by determining the functional characteristics of environmental stimuli associated with their injection, and by determining the effects of self-administered drugs on other ongoing behavior. Interactions between histamine antagonists and frequently co-administered drugs will be studied by determining how histamine antagonists modify the effects of selected opiates, such as morphine and pentazocine, and selected benzodiazepines, such as diazepam. Overall, the proposed research will provide fundamental information about the actions of histamine antagonists in altering and controlling behavior.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In vivo characterization of opioid biased agonists
  • 批准号:
    10062935
  • 项目类别:
  • 资助金额:
    $24.56万
  • 财政年份:
    2019
  • 负责人:
    JACK BERGMAN
  • 依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
  • 批准号:
    10609878
  • 项目类别:
  • 资助金额:
    $55.63万
  • 财政年份:
    2019
  • 负责人:
    JACK BERGMAN
  • 依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
  • 批准号:
    10399441
  • 项目类别:
  • 资助金额:
    $71.84万
  • 财政年份:
    2019
  • 负责人:
    JACK BERGMAN
  • 依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
  • 批准号:
    10152566
  • 项目类别:
  • 资助金额:
    $71.9万
  • 财政年份:
    2019
  • 负责人:
    JACK BERGMAN
  • 依托单位:
海外基金